263 related articles for article (PubMed ID: 28384548)
21. Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker.
Tang J; Do HT; Huber AD; Casey MC; Kirby KA; Wilson DJ; Kankanala J; Parniak MA; Sarafianos SG; Wang Z
Eur J Med Chem; 2019 Mar; 166():390-399. PubMed ID: 30739822
[TBL] [Abstract][Full Text] [Related]
22. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
[TBL] [Abstract][Full Text] [Related]
23. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
[TBL] [Abstract][Full Text] [Related]
24. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.
Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E
Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.
Meleddu R; Cannas V; Distinto S; Sarais G; Del Vecchio C; Esposito F; Bianco G; Corona A; Cottiglia F; Alcaro S; Parolin C; Artese A; Scalise D; Fresta M; Arridu A; Ortuso F; Maccioni E; Tramontano E
ChemMedChem; 2014 Aug; 9(8):1869-79. PubMed ID: 24850787
[TBL] [Abstract][Full Text] [Related]
27. Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action.
Esposito F; Mandrone M; Del Vecchio C; Carli I; Distinto S; Corona A; Lianza M; Piano D; Tacchini M; Maccioni E; Cottiglia F; Saccon E; Poli F; Parolin C; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28637198
[TBL] [Abstract][Full Text] [Related]
28. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.
Kankanala J; Kirby KA; Liu F; Miller L; Nagy E; Wilson DJ; Parniak MA; Sarafianos SG; Wang Z
J Med Chem; 2016 May; 59(10):5051-62. PubMed ID: 27094954
[TBL] [Abstract][Full Text] [Related]
32. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
[TBL] [Abstract][Full Text] [Related]
33. Structural and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse transcriptase.
Yanagita H; Urano E; Matsumoto K; Ichikawa R; Takaesu Y; Ogata M; Murakami T; Wu H; Chiba J; Komano J; Hoshino T
Bioorg Med Chem; 2011 Jan; 19(2):816-25. PubMed ID: 21193314
[TBL] [Abstract][Full Text] [Related]
34. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
[TBL] [Abstract][Full Text] [Related]
35. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
[TBL] [Abstract][Full Text] [Related]
36. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase.
Meleddu R; Distinto S; Corona A; Bianco G; Cannas V; Esposito F; Artese A; Alcaro S; Matyus P; Bogdan D; Cottiglia F; Tramontano E; Maccioni E
Eur J Med Chem; 2015 Mar; 93():452-60. PubMed ID: 25728026
[TBL] [Abstract][Full Text] [Related]
37. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
Ngoutane Mfopa A; Corona A; Eloh K; Tramontano E; Frau A; Boyom FF; Caboni P; Tocco G
Nat Prod Res; 2018 Mar; 32(6):640-647. PubMed ID: 28540745
[TBL] [Abstract][Full Text] [Related]
38. 1,2,4-Triazolo[1,5-
Desantis J; Massari S; Corona A; Astolfi A; Sabatini S; Manfroni G; Palazzotti D; Cecchetti V; Pannecouque C; Tramontano E; Tabarrini O
Molecules; 2020 Mar; 25(5):. PubMed ID: 32151066
[TBL] [Abstract][Full Text] [Related]
39. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
[TBL] [Abstract][Full Text] [Related]
40. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
Brehm JH; Koontz D; Meteer JD; Pathak V; Sluis-Cremer N; Mellors JW
J Virol; 2007 Aug; 81(15):7852-9. PubMed ID: 17507476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
